Self-clearance of Infection: Implications for Lifetime Risk and Population At-risk of Tuberculosis Disease
Overview
Authors
Affiliations
: it is widely assumed that individuals with () infection remain at lifelong risk of tuberculosis (TB) disease. However, there is substantial evidence that self-clearance of infection can occur. We infer a curve of self-clearance by time since infection and explore its implications for TB epidemiology. : data for self-clearance were inferred using post-mortem and tuberculin-skin-test reversion studies. A cohort model allowing for self-clearance was fitted in a Bayesian framework before estimating the lifetime risk of TB disease and the population infected with in India, China and Japan in 2019. We estimated that 24.4% (17.8-32.6%, 95% uncertainty interval (UI)) of individuals self-clear within 10 years of infection, and 73.1% (64.6-81.7%) over a lifetime. The lifetime risk of TB disease was 17.0% (10.9-22.5%), compared to 12.6% (10.1-15.0%) assuming lifelong infection. The population at risk of TB disease in India, China and Japan was 35-80% (95% UI) smaller in the self-clearance scenario. : the population with a viable infection may be markedly smaller than generally assumed, with such individuals at greater risk of TB disease. The ability to identify these individuals could dramatically improve the targeting of preventive programmes and inform TB vaccine development, bringing TB elimination within reach of feasibility.
Boucaid A, Zegmout A, Bhairis M, Amraoui M, Laaraje A, Hassane Kabiri E Cureus. 2025; 16(12):e75740.
PMID: 39816277 PMC: 11732615. DOI: 10.7759/cureus.75740.
Setiabudiawan T, Apriani L, Verrall A, Utami F, Schneider M, Indrati A Nat Commun. 2025; 16(1):309.
PMID: 39747050 PMC: 11695729. DOI: 10.1038/s41467-024-55501-6.
Al Khatib A, Hassanein S, Almari M, Koubar M, Fakhreddine S Front Cell Infect Microbiol. 2024; 14:1423081.
PMID: 39411323 PMC: 11473592. DOI: 10.3389/fcimb.2024.1423081.
Role of Type I Interferons during and HIV Infections.
Anes E, Azevedo-Pereira J, Pires D Biomolecules. 2024; 14(7).
PMID: 39062562 PMC: 11275242. DOI: 10.3390/biom14070848.
Thomsen J, Abdulrazzaq N, Nyasulu P, Al Hosani F, Habous M, Weber S Front Public Health. 2024; 12:1244353.
PMID: 38947352 PMC: 11211529. DOI: 10.3389/fpubh.2024.1244353.